Moreover, the 36-month beta value for RNXT is 1.02. Analysts have varying opinions on the stock, with 4 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for RNXT is 23.54M and currently, short sellers hold a 0.31% of that float. On November 21, 2024, RNXT’s average trading volume was 34.79K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
RNXT) stock’s latest price update
The stock of RenovoRx Inc (NASDAQ: RNXT) has increased by 7.21 when compared to last closing price of 1.11.Despite this, the company has seen a gain of 9.17% in its stock price over the last five trading days. globenewswire.com reported 2024-11-20 that The Northwell Health Cancer Institute is the Most Recent Clinical Site to Join the TIGeR-PaC Study, and RenovoRx Aims to Reach Full Patient Enrollment in the First Half of 2025
RNXT’s Market Performance
RNXT’s stock has risen by 9.17% in the past week, with a monthly rise of 19.00% and a quarterly rise of 22.67%. The volatility ratio for the week is 10.13% while the volatility levels for the last 30 days are 8.91% for RenovoRx Inc The simple moving average for the past 20 days is 12.90% for RNXT’s stock, with a -1.36% simple moving average for the past 200 days.
RNXT Trading at 14.68% from the 50-Day Moving Average
After a stumble in the market that brought RNXT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -49.36% of loss for the given period.
Volatility was left at 8.91%, however, over the last 30 days, the volatility rate increased by 10.13%, as shares surge +21.43% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +13.27% upper at present.
During the last 5 trading sessions, RNXT rose by +9.17%, which changed the moving average for the period of 200-days by -28.74% in comparison to the 20-day moving average, which settled at $1.0541. In addition, RenovoRx Inc saw -48.03% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for RNXT
The total capital return value is set at -1.22. Equity return is now at value -258.95, with -135.25 for asset returns.
Currently, EBITDA for the company is -11.39 million with net debt to EBITDA at 1.28. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.39.
Conclusion
To wrap up, the performance of RenovoRx Inc (RNXT) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
